Search research articles
Contact Us
Filters
Showing results (391-400 of 606) with videos related to
Page
of 61
Sort By:
Neuropsychiatric Disease and Treatment
|
November 10, 2018
Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
Wallace C Duncan, Elizabeth E Slonena, Nadia S Hejazi, et al.
Journal of Affective Disorders
|
April 1, 2014
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, et al.
Journal of Affective Disorders
|
April 23, 2024
Long-term follow-up of participants in ketamine clinical trials for mood disorders
Kelly T Hurst, Abigail Vogeley, Deanna K Greenstein, et al.
Journal of Affective Disorders
|
May 21, 2025
Exploring the link between waking gamma and sleep delta power in healthy volunteers and individuals with treatment-resistant depression
Mina Kheirkhah, Nadia S Hejazi, Allison C Nugent, et al.
Journal of Clinical Psychopharmacology
|
July 14, 2009
Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico
Jorge M Tamayo, Virginia K Sutton, Manuel A Mattei, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 15, 2025
REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression
Mina Kheirkhah, Wallace C Duncan, Qiaoping Yuan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 4, 2024
Clinical and electrophysiological correlates of hopelessness in the context of suicide risk<sup>✰</sup>
Elizabeth D Ballard, Roshni P Nischal, Courtney R Burton, et al.
Orphanet Journal of Rare Diseases
|
April 27, 2019
Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review
Shelagh M Szabo, Ioannis C Tomazos, Anna Petryk, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
June 17, 2020
Control of Murine Primordial Follicle Growth Activation by IκB/NFκB Signaling
Clyde J Wright, Evelyn Llerena Cari, Jeryl Sandoval, et al.
Biological Psychiatry
|
February 12, 2005
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression
Carlos A Zarate, Jorge A Quiroz, Jaskaran B Singh, et al.
Page
of 61
Search research articles
Search
Showing results (391-400 of 606) with videos related to
Sort By:
Page
of 61
Neuropsychiatric Disease and Treatment
|
November 10, 2018
Are 24-hour motor activity patterns associated with continued rapid response to ketamine?
Wallace C Duncan, Elizabeth E Slonena, Nadia S Hejazi, et al.
Journal of Affective Disorders
|
April 1, 2014
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, et al.
Journal of Affective Disorders
|
April 23, 2024
Long-term follow-up of participants in ketamine clinical trials for mood disorders
Kelly T Hurst, Abigail Vogeley, Deanna K Greenstein, et al.
Journal of Affective Disorders
|
May 21, 2025
Exploring the link between waking gamma and sleep delta power in healthy volunteers and individuals with treatment-resistant depression
Mina Kheirkhah, Nadia S Hejazi, Allison C Nugent, et al.
Journal of Clinical Psychopharmacology
|
July 14, 2009
Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico
Jorge M Tamayo, Virginia K Sutton, Manuel A Mattei, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
February 15, 2025
REM density predicts rapid antidepressant response to ketamine in individuals with treatment-resistant depression
Mina Kheirkhah, Wallace C Duncan, Qiaoping Yuan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 4, 2024
Clinical and electrophysiological correlates of hopelessness in the context of suicide risk<sup>✰</sup>
Elizabeth D Ballard, Roshni P Nischal, Courtney R Burton, et al.
Orphanet Journal of Rare Diseases
|
April 27, 2019
Frequency and age at occurrence of clinical manifestations of disease in patients with hypophosphatasia: a systematic literature review
Shelagh M Szabo, Ioannis C Tomazos, Anna Petryk, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
June 17, 2020
Control of Murine Primordial Follicle Growth Activation by IκB/NFκB Signaling
Clyde J Wright, Evelyn Llerena Cari, Jeryl Sandoval, et al.
Biological Psychiatry
|
February 12, 2005
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression
Carlos A Zarate, Jorge A Quiroz, Jaskaran B Singh, et al.
Page
of 61